Prof. Dr. Ulrich Keller

About Prof. Dr. Ulrich Keller

Univ.-Prof. Dr. med. Ulrich Keller is an internationally renowned Haematologist and Medical Oncologist, holding the Chair of Haematology and Oncology with focus on Lymphomas and Multiple Myeloma at one of Europe’s largest university hospitals in Berlin. Since November 2018 he has served as Director of the Department of Hematology, Oncology and Cancer Immunology at the Charité’s Campus Benjamin Franklin and Medical Director of CharitéCenter 14 (Tumor Medicine). He is widely regarded as one of the leading Hematologist specialists in Berlin, Germany for international patients with lymphoma, multiple myeloma and complex blood cancers.

20+ years of clinical and academic experience in haematology and oncology
Director, Medical Department, Division of Hematology, Oncology & Cancer Immunology — Campus Benjamin Franklin (CBF), Charité Berlin (since 1 November 2018)
Medical Director, CharitéCenter 14 (Tumor Medicine) — spanning Campus Benjamin Franklin, Campus Mitte and Campus Virchow-Klinikum
Full Professor (W3) of Haematology & Oncology with focus on Lymphomas / Multiple Myeloma — Charité – Universitätsmedizin Berlin
Former Senior Consultant & Deputy Director, III. Medizinische Klinik, Klinikum rechts der Isar, TU Munich (6 years)
DFG-funded principal investigator with research focus on MYC, lymphomagenesis and AML

Qualifications & Credentials

Medical Degrees

MD & Doctorate (Dr. med.) — Johannes Gutenberg University, Mainz, Germany
Specialist Certification (Facharzt) in Internal Medicine — Klinikum rechts der Isar, TU Munich, 2006
Subspecialty Certification in Haematology & Medical Oncology — Germany
Habilitation & Adjunct Professorship (außerplanmäßiger Professor) — Technical University of Munich (2013)
Full Professorship (W3) — Charité – Universitätsmedizin Berlin (2018)

Fellowships & Special Training

Internal Medicine Specialist Training — Klinikum rechts der Isar, TU Munich
Subspecialty training in Lymphoma, Multiple Myeloma and Stem-Cell Transplantation
Translational research fellowships in molecular oncology / lymphomagenesis

Certifications & Accreditations

Berlin State Medical Council — Registered Specialist
Member, German Society of Haematology and Medical Oncology (DGHO)
Member, European Hematology Association (EHA)
Member, American Society of Hematology (ASH)
Active member, German Cancer Consortium (DKTK) and Berlin Institute of Health (BIH)

Areas of Expertise

Major Conditions Treated

Hodgkin Lymphoma
Non-Hodgkin Lymphomas (DLBCL, Follicular, Mantle Cell, Burkitt)
Multiple Myeloma & Smouldering Myeloma
Chronic Lymphocytic Leukaemia (CLL)
Acute Myeloid Leukaemia (AML)
Acute Lymphoblastic Leukaemia (ALL)
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms
Aplastic Anaemia & Bone Marrow Failure Syndromes
Solid Tumours requiring multidisciplinary oncology care (lung, breast, GI)

Sub-specialties

Lymphoma & Multiple Myeloma: Modern systemic therapy including immunochemotherapy, CAR-T cell therapy, bispecific antibodies and stem-cell transplantation — making him a leading Hematologist specialist Berlin, Germany for lymphoid malignancies.
Acute Leukaemia & AML: Targeted therapy, induction / consolidation chemotherapy and allogeneic transplantation — supporting demand for the best Hematologist doctor in Germany among international referrals.
Translational & Precision Oncology: Identification of cancer-cell vulnerabilities, MYC-driven malignancies and novel drug-target combinations.

Advanced Procedures & Treatments

R-CHOP and Modern Immunochemotherapy Regimens for DLBCL and Lymphomas
CAR-T Cell Therapy for relapsed / refractory B-cell malignancies
Bispecific Antibody Therapy
Autologous Stem Cell Transplantation
Allogeneic Stem Cell Transplantation (matched related, unrelated and haploidentical)
Targeted Therapies (BTK inhibitors, BCL-2 inhibitors, IMiDs, proteasome inhibitors)
Induction and Consolidation Chemotherapy for AML and ALL
PET/CT-Guided Treatment in Hodgkin Lymphoma
Multidisciplinary Tumour Board Coordination

List of Disease and Treatment for which Prof. Dr. Ulrich Keller can be consulted

Professional Experience

Current Affiliation

Director (Ärztlicher Direktor / Klinikdirektor), Medical Department with Focus on Hematology, Oncology and Cancer Immunology — Charité – Universitätsmedizin Berlin, Campus Benjamin Franklin (since 1 November 2018 – Present)
Medical Director, CharitéCenter 14 (Tumor Medicine) — Charité Berlin (Present)
Full Professor (W3) of Haematology & Oncology with focus on Lymphomas / Multiple Myeloma — Charité Berlin (Present)

Past Affiliations

Klinikum rechts der Isar, Technical University of Munich, Germany — Senior Consultant (Leitender Oberarzt) and Deputy Director, III. Medizinische Klinik (Hematology, Oncology & Stem Cell Transplantation), 2012–2018 (~6 years)
Klinikum rechts der Isar, TU Munich — Oberarzt and Adjunct Professor (außerplanmäßiger Professor), 2006–2013
Johannes Gutenberg University, Mainz, Germany — Medical Studies and Doctoral Research

Academic & Research Roles

Full Professor (W3) — Charité – Universitätsmedizin Berlin
Principal Investigator — Keller Group, CBF (Lymphoma, Myeloma and AML research)
DFG-funded research projects on MYC, N-MYC oncoproteins, haematopoiesis and CKS1
Member — German Cancer Consortium (DKTK), Berlin Institute of Health (BIH)
Active mentor — “Clinician Scientist” / “Medical Scientist” training programmes

Key Achievements

Director of one of Germany’s largest haematology / oncology university clinics
Internationally recognised translational research programme on lymphomas, myeloma and AML
Medical Director of Charité’s Tumour Medicine Centre across three campuses
Substantial contribution to clinical trials in DLBCL, multiple myeloma and Hodgkin lymphoma

Awards & Recognitions

National & International Awards

Information not publicly available.

Professional Memberships

German Society of Haematology and Medical Oncology (DGHO)
European Hematology Association (EHA)
American Society of Hematology (ASH)
American Association for Cancer Research (AACR)
German Cancer Consortium (DKTK)
Berlin Institute of Health (BIH)

Research & Publications

Published Papers (Selected)

Keller U, et al. Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma.
Keller U, et al. Fast-Track Schedule for Vitamin D3 Substitution in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.
Keller U, et al. Druggable synthetic lethal interactions in MYC-active pancreatic ductal adenocarcinoma.
Keller U, et al. Combined nivolumab and doxorubicin therapy in classical Hodgkin lymphoma.
Keller U, et al. PET-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma — HD16 Trial Final Results (German Hodgkin Study Group).
Keller U, et al. Treatment with ribociclib shows favourable immunomodulatory effects in HR+ breast cancer (RIBECCA trial).

Ongoing Research & Clinical Interests

MYC and N-MYC oncoproteins in haematopoiesis and lymphomagenesis
Targeted therapies and resistance mechanisms in multiple myeloma
Single-cell sequencing approaches for AML drug discovery
Immunotherapy of Hodgkin and non-Hodgkin lymphomas
Translational research on rewiring of cancer signalling networks

Estimated Treatment Costs

Procedure / Consultation	Estimated Cost (EUR)	Estimated Cost (USD)
Haematology / Oncology Consultation	€300 – €600	$325 – $650
Comprehensive Lymphoma / Myeloma Workup	€5,000 – €12,000	$5,400 – $13,000
R-CHOP / Modern Immunochemotherapy (per cycle)	€8,000 – €18,000	$8,700 – $19,500
CAR-T Cell Therapy (course)	€350,000 – €450,000	$380,000 – $490,000
Autologous Stem Cell Transplantation	€80,000 – €150,000	$87,000 – $163,000
Allogeneic Stem Cell Transplantation	€180,000 – €350,000	$195,000 – $380,000
Targeted Therapy (BTK / BCL-2 inhibitors, per month)	€7,000 – €15,000	$7,600 – $16,300

*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.

Frequently Asked Questions

1. What advanced technologies does Univ.-Prof. Dr. med. Ulrich Keller use in Hematologist treatment?

Univ.-Prof. Dr. med. Ulrich Keller employs the latest evidence-based tools and minimally invasive techniques relevant to Hematologist. Virtual consultations and remote second opinions are also available to international patients. Contact Cancer Rounds for a detailed technology overview specific to your case.

2. What conditions does Univ.-Prof. Dr. med. Ulrich Keller specialize in treating?

Univ.-Prof. Dr. med. Ulrich Keller is a specialist in Hematologist, treating a broad spectrum of conditions in this field — including both common presentations and complex, rare cases. International patients seek treatment for conditions requiring expert Hematologist care in Berlin, Germany.

3. How do I book an appointment with Univ.-Prof. Dr. med. Ulrich Keller?

Appointments with Univ.-Prof. Dr. med. Ulrich Keller can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.

4. Can international patients receive treatment from Univ.-Prof. Dr. med. Ulrich Keller?

Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Univ.-Prof. Dr. med. Ulrich Keller, including medical visa invitation letters, airport transfers, and local accommodation coordination.

5. What support is available for international patients?

International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.

6. Does Univ.-Prof. Dr. med. Ulrich Keller offer second opinions for Hematologist cases?

Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert Hematologist specialist in Berlin, Germany.

About Prof. Dr. Ulrich Keller